The incidence of cardiovascular implantable electronic device (CIED) infection in the U.S. has been increasing for the past two decades, according to work published in…

To many cardiologists, routine use of artificial intelligence (AI) in practice may seem as far off as human travel to Mars—within the realm of possibility but no more around the corner than the red planet is to earth. Such reservations didn’t…

More than 30% of Danish heart patients with an implantable cardioverter-defibrillator (ICD) resume driving during a “banned period” following their index procedure, researchers reported at the ESC Congress in Paris on Sept. 3.

…

Orchestra BioMed, Inc., on Sept. 4 announced it received CE mark approval for its Moderato implantable pulse generation system, which delivers the company’s trademarked cardiac neuromodulation therapy to patients while simultaneously…

Continuous at-home monitoring with smart device-based photoplethysmography (PPG) technology could be a viable strategy for AFib screening and early detection, according to a population-level study out of China.

…

A study of more than 181,000 patients at the Mayo Clinic has proven the efficacy of an AI algorithm in spotting AFib on seemingly normal EKGs, the Daily Mail reports.

The work, led by Paul Friedman, chairman of the…

A combination of 107 chest compressions per minute at a depth of 4.7 centimeters is the optimal CCR-CCD (chest compression rate-chest compression depth) ratio for survival after an out-of-hospital cardiac arrest, researchers reported…

Non-selective His bundle pacing (HBP) is noninferior to selective HBP in patients undergoing de novo permanent pacemaker implantation for bradycardia, according to a study that revealed similar outcomes for death and heart failure (HF)…

The odds a heart patient will experience complications after they’re implanted with a cardiac device vary depending on where they receive care, according to work published in the …

Sixty-nine people have survived out-of-hospital cardiac arrests (OOHCAs) at Hawaii’s airports since an AED program was first implemented in 2006, the Oregonian reports.

Typically, a person’s shot at survival in the…

Medications used to treat atrial fibrillation—namely amiodarone—could increase older patients’ risk of fainting and falling, Danish researchers have found.

Frederik Dalgaard, MD, of Herlev and Gentofte Hospital in Hellerup,…

Despite lower risks for other CVD risk factors, former National Football League players are nearly six times more likely than their non-NFL peers to develop atrial fibrillation, according to a study published in the…

Heart patients exposed to phthalates—a group of chemicals used as plasticizers in the manufacture of plastic medical products—during invasive procedures may be at risk for serious electrophysiological abnormalities, according to a new…

Researchers at the University of Michigan have developed technology that flags stroke victims at the greatest risk for atrial fibrillation after an event, trumping standard methods of risk stratification to achieve greater accuracy. …

Edoxaban and warfarin are equally effective in reducing the risk of stroke, systemic embolic events and major bleeding in patients with atrial fibrillation and a history of liver disease, researchers reported in the…

When Stanford Center for Digital Health Executive Director Mintu Turakhia, MD, MAS, talks about wearable medical devices, he often returns to a few broad themes: the market—what the public is expecting and disruptive companies seem eager to…

Black children, as well as Hispanic kids and other ethnic minorities, are less likely to receive bystander CPR during an out-of-hospital cardiac arrest (OHCA) than their white counterparts, according to a…

Boston Scientific’s Watchman device, an alternative to blood thinners in atrial fibrillation patients unable to take medications like warfarin, has for years been touted as a safe, effective therapy to reduce patients’ stroke risk. But…

Research published in Circulation: Cardiovascular Quality and Outcomes July 9 suggests the public health burden of pulseless in-hospital cardiac…

Biotronik on July 8 announced its BIOMONITOR III injectable cardiac monitor (ICM), a diagnostic tool designed to document suspected arrhythmias, has been cleared by the FDA.

The BIOMONITOR III device is 60% smaller…

Four universities were awarded research grants by the American Heart Association on June 24, each set to receive more than $3.7 million for a range of studies focused on arrhythmias and sudden cardiac arrest.

In a…